News
OGEN
1.060
-2.75%
-0.030
Weekly Report: what happened at OGEN last week (0415-0419)?
Weekly Report · 4d ago
ORAGENICS INC - COMPANY HAS BEGUN TO PREPARE ITS PLAN OF COMPLIANCE FOR SUBMISSION TO NYSE AMERICAN BY MAY 18, 2024 DEADLINE
Reuters · 6d ago
ORAGENICS, INC. ANNOUNCES NOTIFICATION OF NONCOMPLIANCE WITH ADDITIONAL NYSE AMERICAN CONTINUED LISTING STANDARDS
Reuters · 6d ago
Weekly Report: what happened at OGEN last week (0408-0412)?
Weekly Report · 04/15 09:35
Weekly Report: what happened at OGEN last week (0401-0405)?
Weekly Report · 04/08 09:37
Oragenics files 10K and provides company update
Oragenics files 10K and provides company update. The company has acquired a platform technology intended to treat multiple neurological disorders. The first target indication is for concussion. Oragenics raised $2.1 million in a public offering and $890,000 in a private transaction.
Seeking Alpha · 04/01 14:02
Oragenics, Inc. Files 10K And Provides Company Update
Oragenics, Inc. Is a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders. The company has filed its annual report on March 29, 2024. Oragenics acquired a platform technology intended to treat multiple neurological disorders and has successfully completed a Phase I trial for concussion.
Benzinga · 04/01 13:09
Weekly Report: what happened at OGEN last week (0325-0329)?
Weekly Report · 04/01 09:37
Weekly Report: what happened at OGEN last week (0318-0322)?
Weekly Report · 03/25 09:38
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Several key companies are set to release their earnings reports for the week of March 25 to 29. Walgreens Boots Alliance, Carnival, GameStop and more are among the companies scheduled to report next week. The week is shortened by a market holiday on Friday and will be shortened to one day.
Seeking Alpha · 03/24 12:01
Weekly Report: what happened at OGEN last week (0311-0315)?
Weekly Report · 03/18 09:37
Earnings week ahead: FedEx, Nike, XPeng, Tencent, General Mills and more
Earnings week of March 18 to 22 will feature major quarterly updates from FedEx, XPeng, Tencent, General Mills and more. The week will also feature important announcements from Nike, Lululemon Athletica and Chewy. Technology companies are also in focus with earnings results from Micron, Accenture and others.
Seeking Alpha · 03/17 12:20
Weekly Report: what happened at OGEN last week (0304-0308)?
Weekly Report · 03/11 09:36
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Oragenics, Inc. Is preparing to undertake the final steps of manufacturing and formulation of its drug candidate for its expected Phase IIA clinical trial. The drug candidate is expected to be combined with its novel intranasal device for the treatment of mild Traumatic Brain Injury. Oragenics’ lead drug candidate, ONP-002, is designed to target the brain through self-propelled powdered delivery to the brain.
Barchart · 03/05 06:45
Weekly Report: what happened at OGEN last week (0226-0301)?
Weekly Report · 03/04 09:37
Oragenics Inc Enhances Financial Standing with Equity Sale
TipRanks · 03/01 21:26
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
The Dow Jones index fell around 100 points on Wednesday. U.S. Stocks traded lower toward the end of trading. ADT Inc. Reported better-than-expected earnings for its fourth quarter. Vivani Medical, Inc. Shares shot up 274% to $3.78. Asian markets closed lower in Asia Pacific markets.
Benzinga · 02/28 19:30
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ:BMBL) fell sharply after the company reported weak quarterly results. Vivani Medical, Inc. Shares jumped 289% to $3.93 during Wednesday's mid-day session. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate.
Benzinga · 02/28 19:02
12 Health Care Stocks Moving In Wednesday's Intraday Session
Vivani Medical (NASDAQ:VANI) stock increased by 314.4% to $4.19 during Wednesday's regular session. The company's market cap stands at $213.5 million. Adial Pharmaceuticals and vTv Therapeutics moved upwards by 157.73% and 105.88% respectively. Losers Oragenics (AMEX:OGEN) and Novavax stock declined by 42.9%.
Benzinga · 02/28 17:31
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
U.S. Stocks traded lower midway through trading on Wednesday. The Dow traded down 0.19% while the NASDAQ fell 0.31%. Vivani Medical, Inc. Shares shot up 301% to $4.05; real estate shares rose by 1.1% in trading. Crude oil inventories increased by 4.199 million barrels in the week ending Feb. 23, the EIA said. Asian markets closed lower; European shares were mostly lower.
Benzinga · 02/28 17:25
More
Webull provides a variety of real-time OGEN stock news. You can receive the latest news about Oragenics through multiple platforms. This information may help you make smarter investment decisions.
About OGEN
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It is focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an intranasal delivery device. Its lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. It is also focused on developing medical products that treat brain related illnesses and diseases (the Neurology Assets). Its lead product and focus is on the development and commercialization of ONP-002 for the treatment of mTBI.